Study of enicepatide for weight loss in obesity or overweight
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obesity (BMI 30+) or overweight (BMI 27–30) with a weight-related health condition like prediabetes, high blood pressure, or sleep apnea.
- You have tried to lose weight through diet or exercise before but it didn't work.
- You do not have type 1 or type 2 diabetes.
- Your weight has not changed by more than 11 pounds (5 kg) in the last 3 months.
- You have not taken any GLP-1 weight-loss medications (like Wegovy or Ozempic) in the past 6 months.
- You are willing to give yourself injections (or have someone help if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This trial tests if enicepatide can help people with obesity or overweight lose weight, including those with or without type 2 diabetes. It aims to see if the drug is safe and effective.
This early-stage study tests how a new drug called enicepatide is tolerated and processed by the body in generally healthy adults. Researchers want to understand the drug's safety profile before it might be tested in people with specific health conditions.
Hear when a new Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.